Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H P Sinn

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Der Pathologe|January 1, 1997
[DNA cytometry in breast carcinoma. Review of method and value in assessing prognosis]H P Sinn, D Haag, V Ehemann, et al.
Der Radiologe|June 18, 2002
[Comparison of methods for quantifying contrast enhancement exemplified by dynamic MRI mammography]M V Knopp, N Himmelhan, J Radeleff, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
Extensive and predominant in situ component in breast carcinoma: their influence on treatment results after breast-conserving therapyH P Sinn, H W Anton, A Magener, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 1, 1995
Effects of passive immunization against parathyroid hormone-related protein: PTHrP is the responsible factor in mediating hypercalcemia in the Walker carcinosarcoma 256 rat modelT Schilling, E Blind, R Baier, et al.
British Journal of Cancer|December 23, 1998
Aberrant cytoplasmic expression of the p16 protein in breast cancer is associated with accelerated tumour proliferationR Emig, A Magener, V Ehemann, et al.
Zentralblatt Fur Gynakologie|August 15, 1998
[Complete remission after salvage chemotherapy in metastatic breast carcinoma after failure of induction cycles of planned high dosage chemotherapy with stem cell support]E F Solomayer, I J Diel, G Meyberg, et al.
Geburtshilfe Und Frauenheilkunde|October 1, 1994
[Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy]H P Sinn, H Schmid, H Junkermann, et al.
Breast Cancer Research and Treatment|January 1, 1995
Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44H P Sinn, K H Heider, P Skroch-Angel, et al.
Breast (Edinburgh, Scotland)|June 2, 2005
Immunohistochemical evaluation of endothelial nitric oxide synthase expression in primary breast cancerS Loibl, C Strank, G von Minckwitz, et al.
European Radiology|January 24, 2003
Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolutionK Wasser, S K Klein, C Fink, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Der Pathologe|January 1, 1997
[DNA cytometry in breast carcinoma. Review of method and value in assessing prognosis]H P Sinn, D Haag, V Ehemann, et al.
Der Radiologe|June 18, 2002
[Comparison of methods for quantifying contrast enhancement exemplified by dynamic MRI mammography]M V Knopp, N Himmelhan, J Radeleff, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
Extensive and predominant in situ component in breast carcinoma: their influence on treatment results after breast-conserving therapyH P Sinn, H W Anton, A Magener, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 1, 1995
Effects of passive immunization against parathyroid hormone-related protein: PTHrP is the responsible factor in mediating hypercalcemia in the Walker carcinosarcoma 256 rat modelT Schilling, E Blind, R Baier, et al.
British Journal of Cancer|December 23, 1998
Aberrant cytoplasmic expression of the p16 protein in breast cancer is associated with accelerated tumour proliferationR Emig, A Magener, V Ehemann, et al.
Zentralblatt Fur Gynakologie|August 15, 1998
[Complete remission after salvage chemotherapy in metastatic breast carcinoma after failure of induction cycles of planned high dosage chemotherapy with stem cell support]E F Solomayer, I J Diel, G Meyberg, et al.
Geburtshilfe Und Frauenheilkunde|October 1, 1994
[Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy]H P Sinn, H Schmid, H Junkermann, et al.
Breast Cancer Research and Treatment|January 1, 1995
Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44H P Sinn, K H Heider, P Skroch-Angel, et al.
Breast (Edinburgh, Scotland)|June 2, 2005
Immunohistochemical evaluation of endothelial nitric oxide synthase expression in primary breast cancerS Loibl, C Strank, G von Minckwitz, et al.
European Radiology|January 24, 2003
Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolutionK Wasser, S K Klein, C Fink, et al.
Pageof 8